Heart ablation showdown: simpler method may be just as good

NCT ID NCT07118046

Recruiting now Disease control Sponsor: Daniel Rodríguez Muñoz Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study compares two ways to perform a heart ablation for atrial fibrillation: one using only X-ray guidance, and the other adding a 3D mapping system. Researchers want to see if the simpler X-ray-only method is just as effective at isolating the pulmonary veins, which is key to controlling the irregular heartbeat. The trial will enroll 96 adults with paroxysmal or persistent atrial fibrillation who need this procedure.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: pulsed-field ablation via balloon catheter
What this could lead to: If successful, this could show that a simpler, fluoroscopy-only approach is just as effective as using additional mapping technology for treating atrial fibrillation.
What could go wrong: This is a small, early-stage study (96 participants) comparing two techniques, not testing a new drug. It may not show a clear difference, and results may not apply to all patients with atrial fibrillation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrial fibrillation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATRIAL FIBRILLATION

Contacts and locations

Locations

University Hospital 12 de Octubre
RECRUITING

Madrid, Madrid, 28041, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.